Publications found:
400
Sort by:
Intravenous Immunoglobulin Market - 2024-2031
US$ 3,400.00
The Intravenous Immunoglobulin Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliv...
February 2026
52 pages
Biologic Therapeutics Drugs Market - 2024-2031
US$ 3,400.00
Biologic Therapeutics Drugs Marketis is growing with a CAGR of 10.00% during the forecast period 2026-2035. The Biologic Therapeutics Drugs Market emerges as a key focus in DataM Intelligence latest i...
February 2026
53 pages
Immunoglobulin Market - 2024-2031
US$ 3,400.00
Immunoglobulin Marketis is growing with a CAGR of 7.62% during the forecast period 2026-2035. The Immunoglobulin Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where sea...
February 2026
40 pages
Human Growth Hormone Market Size, Share & Trends Analysis Report By Product Type (Branded Products, Biosimilars), By Application, By Dosing Frequency, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2040
US$ 5,950.00
The global human growth hormone (hGH) market is expected to reach USD 7.1 billion by 2025, according to a new report by ... pituitary dysfunction and increasing use of human growth hormone are likely to drive the market in coming years. Turner syndrome, growth hormone deficiency, Prader-Willi syndrome, idiopathic ...
January 2026
150 pages
PEGylated Proteins Market - 2024-2031
US$ 3,400.00
PEGylated Proteins Marketis is growing with a CAGR of 6.80% during the forecast period 2026-2035. The PEGylated Proteins Market emerges as a key focus in DataM Intelligence latest in-depth analysis, w...
January 2026
44 pages
Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vector Type (Viral Vector, Non-Viral Vector), By Delivery Method (In-Vivo, Ex-Vivo), By Indication (Rare Diseases, Cancer, Neurological Diseases, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Gene Therapy Market is projected to expand from USD 7.54 Billion in 2025 to USD 13.02 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 9.53%. Gene therapy is characterize...
January 2026
180 pages
Live Biotherapeutics Products and Microbe CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (C.difficle, Crohns disease, IBS, Diabetes, Others), By Product (APIs, FDFs), By Type of Formulation (Solid Formulations, Oral Liquids, Injectables, Others), By Scale of Operation (Preclinical Scale Operations, Clinical Scale Operations, Commercial Scale Operations), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Live Biotherapeutics Products and Microbe CDMO Market is projected to surge from USD 33.22 Billion in 2025 to USD 226.56 Billion by 2031, expanding at a CAGR of 37.71%. Because Live Biother...
January 2026
185 pages
Advanced Therapy Medicinal Products CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Gene Therapy, Cell Therapy, Tissue Engineered, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (Oncology, Cardiology, Central Nervous System, Musculoskeletal, Infectious disease, Immunology & inflammation, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Advanced Therapy Medicinal Products CDMO Market is projected to increase from USD 5.23 Billion in 2025 to USD 9.06 Billion by 2031, reflecting a compound annual growth rate of 9.59%. These...
January 2026
185 pages
Regulatory T-cells (Tregs) Therapies Market - Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Type (Autologous, Allogenic), By Applications (Autoimmune Diseases, Organ Transplantation, Graft-versus-Host Disease (GVHD), Others), By End-User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Regulatory T-cells (Tregs) Therapies Market is projected to experience substantial growth, expanding from a valuation of USD 2.77 Billion in 2025 to USD 22.75 Billion by 2031, reflecting a...
January 2026
185 pages
Automated And Closed Cell Therapy Processing Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Workflow (Separation, Expansion, Apheresis, Fill-Finish, Cryopreservation, Others), By Type (Stem Cell Therapy, Non-Stem Cell Therapy), By Scale (Pre-commercial/ R&D Scale, Commercial Scale), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Automated And Closed Cell Therapy Processing Systems Market is projected to expand from USD 931.08 Million in 2025 to USD 1593.59 Million by 2031, achieving a compound annual growth rate of...
January 2026
185 pages
Monoclonal Antibody Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Naked, Fusion Protein, Antibody Fragment, Conjugate, Multi-specific), By Application (Cancer, Autoimmune Diseases, Infectious Diseases, Others), By Production Source (Human, Humanized, Chimeric, Others), By End User (Hospital, Specialty Centers, Research Institutes), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Monoclonal Antibody Therapeutics Market is projected to expand from USD 247.21 Billion in 2025 to USD 425.67 Billion by 2031, reflecting a compound annual growth rate of 9.48%. These therap...
January 2026
180 pages
Large Molecule Drug Substance CDMO Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Service (Contract Manufacturing, Contract Development), By Source (Mammalian, Microbial, Others), By End User (Biotech Companies, CRO, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Large Molecule Drug Substance CDMO Market is projected to expand from USD 12.85 Billion in 2025 to USD 22.28 Billion by 2031, registering a CAGR of 9.61%. Organizations in this sector deliv...
January 2026
181 pages
PEGylated Proteins Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Consumable (PEGylation Kits and Reagents (Monofunctional Linear PEGs, Bifunctional PEGs, others), PEGylation Kits), Services), By Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII and Others), By Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders and Others), By End-Use (Pharmaceuticals, Biotechnology Companies, CROs and Academic Research Institutes, others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global PEGylated Proteins Market is projected to expand considerably, growing from USD 1051.35 Million in 2025 to USD 1854.63 Million by 2031, reflecting a CAGR of 9.92%. These therapeutic molecul...
January 2026
182 pages
Biologics Drug Discovery Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Monoclonal Antibodies, Recombinant Proteins, Others), By Method (Target Identification/ validation, Hit Generation/ Validation, Lead Identification, Lead Optimization), By Manufacture Type (In-House, Outsourced), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Biologics Drug Discovery Market is projected to expand from a valuation of USD 9.66 Billion in 2025 to USD 15.49 Billion by 2031, reflecting a CAGR of 8.19%. This sector focuses on the rese...
January 2026
181 pages
Cell and Gene Therapy Manufacturing QC Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy Type (Cell Therapy, Gene Therapy), By Offering (Instruments, Consumables, Others), By Process (Raw Material Preparation, Upstream Processing, Downstream Processing, Packaging), By Technology (Polymerase Chain Reaction (PCR), Flow Cytometry, Limulus Amebocyte Lysate (LAL), Enzyme-Linked Immunosorbent Assay (ELISA), Chromatography, Mass Spectrometry, Western Blotting, Next-Generation Sequencing (NGS), Electrophoresis, Others), By Application (Safety Testing, Potency Testing, Identity Testing, Stability and Genetic Fidelity Testing, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cell and Gene Therapy Manufacturing QC Market is projected to expand from USD 1.35 Billion in 2025 to USD 2.01 Billion by 2031, reflecting a compound annual growth rate of 6.87%. This secto...
January 2026
180 pages
Cell Therapy Human Raw Materials Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents & Buffers, Other), By End User (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutions), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cell Therapy Human Raw Materials Market is projected to expand from USD 3.01 Billion in 2025 to USD 6.08 Billion by 2031, registering a CAGR of 12.43%. These raw materials encompass biologi...
January 2026
180 pages
Intravenous Immunoglobulin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (IgG, IgA, IgM, IgE, IgD), By Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, and Other Applications) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Intravenous Immunoglobulin Market is projected to expand from USD 13.41 Billion in 2025 to USD 21.01 Billion by 2031, registering a compound annual growth rate of 7.77%. Derived from the po...
January 2026
180 pages
Autologous Cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source (Bone Marrow, Epidermis, Mesenchymal Stem Cells, Haematopoietic Stem Cells, Chondrocytes, Others), By Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Others), By End User (Hospitals & Clinics, Ambulatory Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Autologous Cell Therapy Market is projected to expand from USD 6.37 Billion in 2025 to USD 8.98 Billion by 2031, reflecting a compound annual growth rate of 5.89%. This therapeutic approach...
January 2026
180 pages
Adeno Associated Virus Vector Manufacturing Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Scale of Operation (Clinical, Preclinical, Commercial), By Method (In Vitro, In Vivo), By Therapeutics Area (Hematological Diseases, Infectious Diseases, Genetic Disorders, Neurological Disorders, Ophthalmic Disorders, Others), By Application (Cell Therapy, Gene Therapy, Vaccine), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Adeno-Associated Virus (AAV) Vector Manufacturing Market is projected to expand from USD 1.48 Billion in 2025 to USD 2.98 Billion by 2031, registering a CAGR of 12.37%. AAV vectors act as e...
January 2026
185 pages
Hematopoietic Stem Cell Transplantation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Allogeneic, Autologous), By Indication (Leukemia, Lymphatic Disorder, Myeloma, Other), By Application (Bone Marrow Transplant; Peripheral Blood Stem Cell Transplant; Cord Blood Transplant), By End User (Hospital Pharmacy, Retail Pharmacy, Specialty Clinics), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Hematopoietic Stem Cell Transplantation Market is projected to expand from USD 3.09 Billion in 2025 to USD 4.62 Billion by 2031, registering a CAGR of 6.93%. This therapeutic sector involve...
January 2026
185 pages
Antibodies Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source (Human mAb, Humanized mAb, Chimeric mAb, and Murine mAb), By Product (Monoclonal Antibodies and Antibody-drug conjugates), By Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, and Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Antibodies Drug Market is projected to expand significantly, rising from USD 79.36 Billion in 2025 to USD 159.52 Billion by 2031, reflecting a compound annual growth rate of 12.34%. Antibod...
January 2026
185 pages
Complement C4 Antibody Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Polyclonal Antibodies, Monoclonal Antibodies, Recombinant Antibodies), By Application (Immunoassays, Western Blotting, Immunohistochemistry, Flow Cytometry, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Clinical Diagnostic Laboratories, Hospitals & Specialty Clinics), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Complement C4 Antibody Market is projected to experience substantial growth, increasing from a value of USD 22.78 Billion in 2025 to USD 45.64 Billion by 2031, with a compound annual growth...
January 2026
180 pages
Bispecific Antibodies Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Indication (Cancer, Inflammatory & Autoimmune Disorders, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Bispecific Antibodies Market is projected to expand from USD 7.44 Billion in 2025 to USD 12.76 Billion by 2031, reflecting a compound annual growth rate of 9.41%. These therapeutics are eng...
January 2026
180 pages
Protein Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Protein Function (Enzymatic & Regulatory, Protein Diagnostics, Vaccines), By Product Type (Blood Clotting Factor, Erythropoietin, Follicle Stimulating Hormone, G-CSF, Insulin, Interferons, Monoclonal Antibodies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Protein Therapeutics Market is projected to expand from USD 301.19 Billion in 2025 to USD 447.46 Billion by 2031, achieving a CAGR of 6.82%. These therapeutics consist of pharmacologically...
January 2026
181 pages
Cell Therapy Manufacturing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies), By Source of Cell (Autologous v/s Allogenic), By Scale of Operation (Preclinical, Clinical, Commercial), By Source (In-House v/s Contract Manufacturing), By Application (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cell Therapy Manufacturing Market is projected to expand from USD 5.71 Billion in 2025 to USD 11.42 Billion by 2031, reflecting a compound annual growth rate of 12.25%. This sector comprise...
January 2026
185 pages
Plasma Protein Therapeutics Market ? Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Immunoglobulin, Albumin, Plasma Derived Clotting Factor, Fibrinogen, Others), By Application (Hemophilia, Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura (ITP), Others), By End User (Hospitals, Research Laboratories and Institutions, Stand-Alone Blood Banks, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Plasma Protein Therapeutics Market is projected to expand from USD 33.26 Billion in 2025 to USD 49.27 Billion by 2031, reflecting a CAGR of 6.77%. These biologic medicines, obtained through...
January 2026
181 pages
Biologics Market - 2026-2032
US$ 3,400.00
Biologics Market reached US$ 472.71 billion in 2023 and is expected to reach US$ 966.98 billion by 2033, growing with a CAGR of 7.10% during the forecast period 2026-2033. The Biologics Market emerges...
January 2026
35 pages
